Mira Pharmaceuticals Inc (MIRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,409 | -1,718 | -11,982 | -6,195 | -2,607 |
| Depreciation Amortization | N/A | N/A | N/A | 732 | 293 |
| Other Working Capital | 391 | 168 | -640 | -351 | -312 |
| Other Operating Activity | 1,105 | 500 | 8,090 | 2,317 | 890 |
| Operating Cash Flow | $-1,914 | $-1,050 | $-4,532 | $-3,497 | $-1,736 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 2,148 | N/A | N/A |
| Common Stock Issued | N/A | 0 | 7,704 | 9,054 | N/A |
| Other Financing Activity | 135 | -24 | -1,068 | -40 | 1,410 |
| Financing Cash Flow | $135 | $-24 | $8,784 | $9,015 | $1,410 |
| Beginning Cash Position | 4,603 | 4,603 | 351 | 351 | 351 |
| End Cash Position | 2,824 | 3,529 | 4,603 | 5,868 | 25 |
| Net Cash Flow | $-1,779 | $-1,074 | $4,252 | $5,517 | $-326 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,914 | -1,050 | -4,532 | -3,497 | -1,736 |
| Free Cash Flow | -1,914 | -1,050 | -4,532 | -3,497 | -1,736 |